Access to novel technology like renal denervation allows new options for a group of patients at high risk for cardiovascular events that are not responding to drug therapy.
Assurex Canada helps healthcare providers tailor the right treatment to patients using a genetic test called Gene Sight™ , which is displacing the current trial and error approach to prescribing medication for behavioral health conditions.
Mild brain injury is very common and accounts for 66-75% of all hospital admissions for head trauma.
Most persons with mild TBI generally report a similar pattern of symptoms which include physical, cognitive and emotional/behavioral challenges.
The condition affects ~7% of adults in North America (18 million people), however 87% of them are undiagnosed and untreated, due to high cost and inconvenience associated with overnight monitoring at sleep labs. is a trusted Canadian leader delivering innovative health system solutions and advanced medical technologies to alleviate pain, restore health, and extend life in the areas of cardiovascular medicine, diabetes, spinal and neurosurgery, and ear, nose, throat surgery.
Medtronic employs more than 720 Canadians, with offices in Brampton, Montreal and Vancouver.
It also incorporates genetic markers discovered by the Centre for Addiction and Mental Health (CAMH).Founded by the University Health Network (UHN) and Ma RS Innovation (MI), Breso Tec is a Canadian start-up featuring technology developed by i DAPT Research of TRI, a member of UHN.i DAPT Research is the world’ largest research organization in assistive technologies.In addition, our software records patient symptomatology.The second element of our technology is a device (CEBUS) that is used both in evaluation and rehabilitation.
Ably Bed is inspired by the professional spirit found among the nursing and medical personnel themselves.